Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 10, 2021New England Journal of MedicineOpen Access

Once-Weekly Semaglutide in Adults with Overweight or Obesity

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJohn WildingRBRachel L. BatterhamSCSalvatore Calanna

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wilding et al. (2021) studied this question.

synapsesocial.com/papers/68fe3f1c51dfe03b6a003bc1https://doi.org/10.1056/nejmoa2032183
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial2018 · 822 citations